JoVE Logo
Faculty Resource Center

Sign In

Etablering og karakterisering af tre Afatinib-resistente lunge adenokarcinom PC-9 cellelinjer udviklet med stigende doser Afatinib

DOI :

10.3791/59473-v

June 26th, 2019

June 26th, 2019

7,690 Views

1Advanced Cancer Translational Research Institute, Showa University, 2Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, 3Division of Allergology and Respiratory Medicine, Department of Medicine, Showa University School of Medicine

En metode til at etablere afatinib-resistens cellelinjer fra lunge adenokarcinom PC-9 celler blev udviklet, og resistente celler blev karakteriseret. De resistente celler kan bruges til at undersøge epidermal vækstfaktor receptor tyrosinkinase hæmmer-resistensmekanismer, der gælder for patienter med ikke-småcellet lungekræft.

Tags

Kr ftforskning

-- Views

Related Videos

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved